Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.90
Bid: 29.10
Ask: 30.70
Change: 0.10 (0.34%)
Spread: 1.60 (5.498%)
Open: 29.80
High: 0.00
Low: 0.00
Prev. Close: 29.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Wed, 02nd Dec 2020 09:55

(Alliance News) - Concepta PLC on Wednesday said it has launched a Covid-19 genomic testing kit, and the myLotus pregnancy test maker also outlined plans for a name change.

Shares in Concepta jumped 32% to 2.12 pence each in London on Wednesday morning.

The healthcare company and fertility tracking firm launched a DNA testing service under the MyHealthChecked brand, in the wake of Concepta's acquisition of Genome Store Ltd, announced in November.

Concepta parted with an initial GBP280,000 to buy the home-use genetic testing company, plus a deferred consideration of up to GBP240,000.

The company said the test will be a "COVID-19 lab-based PCR test".

"The MyHealthChecked Covid-19 testing service will use the Clarigene SARS-CoV-2 test supplied by Yourgene Health PLC and the PrimeStore MTM sample collection device supplied by EKF Diagnostic Holdings PLC," Concepta added.

"The MyHealthChecked testing service allows samples to be quickly and conveniently taken at home using simple nasal collection swabs which are then sent via free postage for processing using established laboratory-based DNA and RNA detection methods."

Looking ahead, Concepta said it plans to launch a "number of DNA tests", in fields such as male and female wellness and food intolerance.

"Our priority is to look beyond the pandemic with a range of affordable, meaningful at-home test kits, but it would be remiss of us - now with the expertise and operational channel in-house - not to make this kit available to the public," Concepta Chief Executive Officer Penny McCormick said.

The company added that the "requirement for at home testing kits is expected to continue", despite promising news on the vaccine front.

The UK government on Wednesday said it has authorised Pfizer Inc and BioNTech SE's Covid-19 vaccine, becoming the first country in the world to give the jab the green light.

In changes that will take effect in "due course" Concepta said its name will change to MyHealthChecked PLC.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Nov 2020 09:44

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

UK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next

Read more
9 Nov 2020 11:57

EKF Diagnostics Says Annual Performance To Be Ahead Of Expectations

EKF Diagnostics Says Annual Performance To Be Ahead Of Expectations

Read more
9 Nov 2020 10:18

EKF Diagnostics trades ahead of FY expectations

(Sharecast News) - Point-of-care business EKF Diagnostics said on Monday that it looked set to trade ahead of market expectations for the full year.

Read more
28 Oct 2020 17:43

UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot

UK TRADING UPDATE SUMMARY: Shoe Zone Ends Financial Year On Back Foot

Read more
22 Oct 2020 09:43

EKF Diagnostics secures new orders for Covid-19 sample collection devices

(Sharecast News) - Point-of-care business EKF Diagnostics has received orders for its Covid-19 sample collection devices from two new customers.

Read more
2 Oct 2020 15:45

IN BRIEF: EKF Diagnostics Expects 2020 Results To Meet Expectations

IN BRIEF: EKF Diagnostics Expects 2020 Results To Meet Expectations

Read more
14 Sep 2020 12:32

EKF Diagnostics To Pay Maiden Dividend Amid Covid-19 Testing Boost

EKF Diagnostics To Pay Maiden Dividend Amid Covid-19 Testing Boost

Read more
20 Aug 2020 18:58

IN BRIEF: EKF Diagnostics Invests USD5 Million In Trellus Health

IN BRIEF: EKF Diagnostics Invests USD5 Million In Trellus Health

Read more
5 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

Read more
5 Aug 2020 09:16

EKF Diagnostics receives further orders for Covid-19 testing kits

(Sharecast News) - Point-of-care business EKF Diagnostics has received an initial order worth more than £3.0m to supply its PrimeStore MTM collection device to a private sector partner for use in a Covid-19 testing programme.

Read more
14 Jul 2020 16:50

UK TRADING UPDATE SUMMARY: Sales Rise For EKF Covid-19 Sample Product

UK TRADING UPDATE SUMMARY: Sales Rise For EKF Covid-19 Sample Product

Read more
3 Jun 2020 16:09

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
5 May 2020 16:23

EKF Diagnostics Signs Distribution Deal With Chemicals Firm Tosoh

EKF Diagnostics Signs Distribution Deal With Chemicals Firm Tosoh

Read more
5 May 2020 15:23

EKF Diagnostics signs distribution deal with Tosoh Europe

(Sharecast News) - Point-of-care company EKF Diagnostics has signed a three-year distribution agreement with Tosoh Europe, part of chemical supply and specialty materials company Tosoh Corporation, for the distribution of its 'Quo-Test' HbA1c Analyzer in the Middle East and Africa.

Read more
29 Apr 2020 10:59

EKF Diagnostics to supply collection device for Covid-19 testing

(Sharecast News) - Point-of-care business EKF Diagnostics Holdings has signed an agreement with Source BioScience to supply a novel patented sample collection device for its growing Covid-19 testing service.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.